Ziftomenib showed significant efficacy in relapsed/refractory NPM1-mutant AML, achieving deep, durable responses in the KOMET-001 trial. The trial enrolled 92 patients, with 23% achieving complete ...
Phase One unveils advanced drone camera integration systems at Intergeo 2025, featuring new UAV compatibility and processing software.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback